Biogen (BIIB)
(Delayed Data from NSDQ)
$199.36 USD
-2.08 (-1.03%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $199.26 -0.10 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 3.81 |
EPS Last Quarter | 5.28 |
Last EPS Surprise | 32.00% |
ABR | 1.62 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 16.12 |
Next Year | 17.10 |
EPS (TTM) | 16.26 |
P/E (F1) | 12.36 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.44B | 2.45B | 9.64B | 9.56B |
# of Estimates | 21 | 21 | 23 | 23 |
High Estimate | 2.57B | 2.61B | 9.93B | 10.34B |
Low Estimate | 2.36B | 2.26B | 9.41B | 8.89B |
Year ago Sales | 2.53B | 2.39B | 9.84B | 9.64B |
Year over Year Growth Est. | -3.74% | 2.46% | -2.03% | -0.75% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.81 | 3.38 | 16.12 | 17.10 |
# of Estimates | 20 | 18 | 22 | 22 |
Most Recent Consensus | 3.70 | 3.39 | 16.46 | 16.82 |
High Estimate | 4.45 | 3.76 | 16.87 | 22.44 |
Low Estimate | 3.44 | 2.61 | 15.39 | 13.98 |
Year ago EPS | 4.36 | 2.95 | 14.72 | 16.12 |
Year over Year Growth Est. | -12.61% | 14.58% | 9.51% | 6.05% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 1 | 20 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 14 | 16 | 1 | 14 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 3.81 | 3.38 | 16.12 | 17.10 |
7 Days Ago | 3.81 | 3.38 | 16.12 | 17.10 |
30 Days Ago | 3.81 | 3.46 | 16.10 | 16.95 |
60 Days Ago | 3.99 | 3.94 | 15.64 | 17.37 |
90 Days Ago | 4.00 | 3.95 | 15.64 | 17.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.81 | 3.38 | 16.12 | 17.10 |
Zacks Consensus Estimate | 3.81 | 3.38 | 16.12 | 17.10 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 5.28 | 3.67 | 2.95 | 4.36 | NA |
Estimate | 4.00 | 3.45 | 3.16 | 3.99 | NA |
Difference | 1.28 | 0.22 | -0.21 | 0.37 | 0.42 |
Surprise | 32.00% | 6.38% | -6.65% | 9.27% | 10.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more